Showing results (81-90 of 940) with videos related to
Sort By:
Pageof 94
Critical Care (London, England)|September 11, 2009
Nebulized antithrombin limits bacterial outgrowth and lung injury in Streptococcus pneumoniae pneumonia in ratsJorrit J Hofstra, Alexander D Cornet, Bart F de Rooy, et al.Immunity|November 10, 2021
The immunology of sepsisTom van der Poll, Manu Shankar-Hari, W Joost WiersingaJournal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivoSylvia Knapp, Ulrich Matt, Norbert Leitinger, et al.Expert Review of Anti-Infective Therapy|June 26, 2014
The coagulation system in melioidosis: from pathogenesis to new treatment strategiesLiesbeth Martine Kager, Tom van der Poll, Willem Joost WiersingaMicrobes and Infection|July 26, 2008
Gene-expression profiles in murine melioidosisW Joost Wiersinga, Mark C Dessing, Tom van der PollBiomedicines|September 23, 2022
The End of "One Size Fits All" Sepsis Therapies: Toward an Individualized ApproachJean-Louis Vincent, Tom van der Poll, John C MarshallWorld Journal of Stem Cells|March 28, 2015
Mesenchymal stem cells as a therapeutic tool to treat sepsisEleuterio Lombardo, Tom van der Poll, Olga DelaRosa, et al.Blood|April 19, 2003
Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumoniaAnita W Rijneveld, Sandrine Florquin, Paul Bresser, et al.The Journal of Infectious Diseases|June 8, 2004
Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in miceSebastian Weijer, Saskia H H F Schoenmakers, Sandrine Florquin, et al.The Journal of Infectious Diseases|October 8, 2010
Therapeutic recombinant murine activated protein C attenuates pulmonary coagulopathy and improves survival in murine pneumococcal pneumoniaMarcel Schouten, Cornelis van 't Veer, Florry E van den Boogaard, et al.Pageof 94